When tested in neuroblastoma cell lines, the compound induced G1 arrest and apoptosis in p53 wild-type cells, but similar to SAM486A treatment, only induced growth inhibition in p53 mutant cells (Soderstjerna et al., 2010). The gene discussed is TP53; the disease is neuroblastoma.